Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency and Niche of Bulge Stem Cell01:06

Multipotency and Niche of Bulge Stem Cell

4.0K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
4.0K
Accessory Structures of the Skin: Hair Growth and Types01:20

Accessory Structures of the Skin: Hair Growth and Types

2.1K
Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical response and time to improvement with 308-nm excimer laser therapy in scarring alopecia: a retrospective cohort study.

The Journal of dermatological treatment·2026
Same author

Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

Journal of the American Academy of Dermatology·2026
Same author

Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026
Same author

Sparse Insurance and Alopecia Information Availability Among New York City Wig Providers: A Cross-Sectional Study.

Journal of the American Academy of Dermatology·2026
Same author

Safety and clinical considerations of alopecia therapies during pregnancy, fertility treatment, and polycystic ovary syndrome workup.

International journal of women's dermatology·2026
Same author

Follicular Disorders Associated With Pseudofolliculitis Barbae: A TriNetX Retrospective Cohort Study.

International journal of dermatology·2026
Same journal

Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.

Journal of drugs in dermatology : JDD·2026
Same journal

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation.

Journal of drugs in dermatology : JDD·2026
Same journal

Decoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America.

Journal of drugs in dermatology : JDD·2026
Same journal

Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans.

Journal of drugs in dermatology : JDD·2026
Same journal

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review.

Journal of drugs in dermatology : JDD·2026
See all related articles

Related Experiment Video

Updated: Nov 23, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.2K

Laboratory Testing in Telogen Effluvium.

Efe Kakpovbia, Oluwatobi A Ogbechie-Godec, Jerry Shapiro

    Journal of Drugs in Dermatology : JDD
    |January 5, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Telogen effluvium, a common cause of hair loss, lacks standardized evidence-based treatments. This review addresses the need for improved clinical protocols for managing this non-scarring condition.

    More Related Videos

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
    03:22

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

    Published on: January 27, 2018

    15.4K
    Collecting Hair Samples for Hair Cortisol Analysis in African Americans
    06:01

    Collecting Hair Samples for Hair Cortisol Analysis in African Americans

    Published on: June 10, 2018

    18.9K

    Related Experiment Videos

    Last Updated: Nov 23, 2025

    A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
    06:41

    A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

    Published on: March 9, 2015

    9.2K
    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
    03:22

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

    Published on: January 27, 2018

    15.4K
    Collecting Hair Samples for Hair Cortisol Analysis in African Americans
    06:01

    Collecting Hair Samples for Hair Cortisol Analysis in African Americans

    Published on: June 10, 2018

    18.9K

    Area of Science:

    • Dermatology and Trichology

    Background:

    • Telogen effluvium (TE) is a prevalent form of non-scarring alopecia.
    • Current management strategies for TE are diverse due to limited evidence-based guidelines.

    Discussion:

    • The paucity of robust clinical evidence necessitates a critical evaluation of existing TE treatment protocols.
    • Standardizing diagnostic and therapeutic approaches is crucial for effective patient management.

    Key Insights:

    • Identifying key factors influencing TE pathogenesis is essential for developing targeted therapies.
    • Clinical protocols should be informed by the best available scientific evidence to improve outcomes.

    Outlook:

    • Future research should focus on generating high-quality evidence to support standardized TE management.
    • Developing evidence-based guidelines will enhance clinical practice and patient care for telogen effluvium.